跳至主要内容
临床试验/JPRN-UMIN000013193
JPRN-UMIN000013193招募中未知

Prophylaxis of post-ERCP pancreatitis by the intravenous administration of the non-steroidal anti-inflammatory drug - Intravenous flurbiprofen axetil for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis

Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine, Tokyo, Japan0 个研究点目标入组 400 人开始时间: 2014年2月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The following patients were excluded: those with contraindications to flurbiprofen axetil, those who had taken any NSAID during the preceding week, those diagnosed with acute pancreatitis during the month before ERCP, those with an anticipated low risk of PEP (those with chronic calcific pancreatitis or a pancreatic head tumor or those undergoing routine biliary stent exchange), and those who did not agree to participate in the study.

研究者

发起方
Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine, Tokyo, Japan

相似试验